China Universal Asset Management Co., Ltd. Bei Gene, Ltd. Transaction History
China Universal Asset Management Co., Ltd.
- $773 Million
- Q1 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 7,991 shares of BGNE stock, worth $1.18 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
7,991
Previous 7,991
-0.0%
Holding current value
$1.18 Million
Previous $1.25 Million
0.08%
% of portfolio
0.16%
Previous 0.16%
Shares
12 transactions
Others Institutions Holding BGNE
# of Institutions
216Shares Held
45.1MCall Options Held
76.5KPut Options Held
72.3K-
Baker Bros. Advisors LP New York, NY10.6MShares$1.56 Billion20.93% of portfolio
-
Capital International Investors Los Angeles, CA7.06MShares$1.05 Billion0.23% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$766 Million17.98% of portfolio
-
Primecap Management CO Pasadena, CA5MShares$740 Million0.59% of portfolio
-
Baillie Gifford & CO3.73MShares$552 Million0.46% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $15.3B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...